Keen Vision Acquisition Quote - KVAC

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

11.10

Bid

11.09

Ask

11.10

Volume

1,532

11.0999 Day's Range 11.10

10.37 52 Week Range 11.10

Market Cap

214.963M

Previous Close

11.08

Open

11.10

Last Trade

11.1

Last Trade Time

14:29:22

Financial Volume

US$ 17,005

VWAP

11.10

Average Volume (3m)

13,518

Shares Outstanding

19,366,000

Dividend Yield

PE Ratio

147.80

Earnings Per Share (EPS)

0.08

Revenue

Net Profit

1.46M

Sector

Blank Checks

Industry

Blank Checks

Headquarters

Road Town, Tortola, Vgb

Founded

Keen Vision Acquisition Corporation is listed in the Blank Checks sector of the NASDAQ with ticker KVAC. The last closing price for Keen Vision Acquisition was US$11.08. Over the last year, Keen Vision Acquisition shares have traded in a share price range of US$ 10.37 to US$ 11.10.

Keen Vision Acquisition currently has 19,366,000 shares outstanding. The market capitalization of Keen Vision Acquisition is US$214.58 million. Keen Vision Acquisition has a price to earnings ratio (PE ratio) of 147.80.

Medera’s Novoheart and Curi Bio Partner to Transform Human-Based Cardiac Drug Screening

Innovative Technology Integration: The strategic partnership seamlessly integrates the unique ability of Novoheart’s human "Heart-in-a-Jar" to assess cardiac pump performance with Curi Bio’s...

Medera’s Novoheart Releases Latest Cardiac Screening Innovation CTScreen v1.5 to Advance High-Throughput, Automated Human-Based Drug Testing

Innovation installed by AstraZeneca for advancing human heart-based R&D for investigational cardiovascular therapiesFeatures improved automation, environmental control, and flexible testing...

Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology

Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology PR Newswire SUMMIT, N.J. and BOSTON, Mass., Oct. 31...

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection Fraction

Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with...

Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation

Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation PR Newswire SUMMIT, N.J. and BOSTON, Sept. 5, 2024 Medera is a clinical-stage biotechnology...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.04	0.361663652803	11.06	11.1	11.06	12634	11.07667569	CS
4	0.12	1.09289617486	10.98	11.1	10.98	4703	11.06391875	CS
12	0.23	2.11591536339	10.87	11.1	10.87	13518	10.94511707	CS
26	0.31	2.87303058387	10.79	11.1	10.62	56706	10.75743649	CS
52	0.71	6.83349374398	10.39	11.1	10.37	63705	10.61964652	CS
156	0.9	8.82352941176	10.2	11.1	10.14	68370	10.498214	CS
260	0.9	8.82352941176	10.2	11.1	10.14	68370	10.498214	CS

KVAC - Frequently Asked Questions (FAQ)

What is the current Keen Vision Acquisition share price?

The current share price of Keen Vision Acquisition is US$ 11.10

How many Keen Vision Acquisition shares are in issue?

Keen Vision Acquisition has 19,366,000 shares in issue

What is the market cap of Keen Vision Acquisition?

The market capitalisation of Keen Vision Acquisition is USD 214.58M

What is the 1 year trading range for Keen Vision Acquisition share price?

Keen Vision Acquisition has traded in the range of US$ 10.37 to US$ 11.10 during the past year

What is the PE ratio of Keen Vision Acquisition?

The price to earnings ratio of Keen Vision Acquisition is 147.8

What is the reporting currency for Keen Vision Acquisition?

Keen Vision Acquisition reports financial results in USD

What is the latest annual profit for Keen Vision Acquisition?

The latest annual profit of Keen Vision Acquisition is USD 1.46M

What is the registered address of Keen Vision Acquisition?

The registered address for Keen Vision Acquisition is RITTER HOUSE, WICKHAMS CAY II, PO BOX 3170, ROAD TOWN, TORTOLA, VG1110

Which industry sector does Keen Vision Acquisition operate in?

Keen Vision Acquisition operates in the BLANK CHECKS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	US$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	US$ 0.00 (0.00%)	0
AACGATA Creativity Global	US$ 0.00 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	US$ 0.00 (0.00%)	0
AACGATA Creativity Global	US$ 0.00 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 0.00 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.00 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 0.00 (0.00%)	0
AADIAadi Bioscience Inc	US$ 0.00 (0.00%)	0
AACGATA Creativity Global	US$ 0.00 (0.00%)	0